Sardis Capital Group
Commercial strategy, market intelligence, and capital connectivity for companies building ahead of the market.
Sardis helps companies build commercial momentum in complex markets, strengthen their ecosystems, and access select capital pathways.
Four ways Sardis
creates leverage.
Commercial Architecture
We identify the market to win first, define the ICP, map the buyer journey, structure the pilot, and build the commercial sequence that turns an impressive product into repeatable revenue.
Ecosystem Development
Complex markets move through trusted relationships. Sardis maps the buyers, partners, platforms, investors, and institutional stakeholders that can accelerate adoption — and builds the pathways that connect them.
Market Formation Intelligence
We monitor regulatory forcing functions, funding dynamics, buyer behavior, infrastructure requirements, and ecosystem activation signals. The purpose is not to summarize what the market already knows. It is to identify what is forming before it becomes consensus.
Capital & Co-Investment
For select companies with strong founder-market fit, a credible financing lead, defined terms, and a meaningful remaining allocation, Sardis may evaluate opportunities for participation through Sardis Circle, a deal-specific vehicle, or an aligned syndication partner.
Learn about Capital & Co-Investment→How We See the Market
Sardis operates a continuous intelligence function that monitors regulatory forcing functions, funding dynamics, and consciousness shifts across sovereignty markets. Clients receive intelligence specific to their GTM motion and buyer landscape — not a summary of what everyone already knows, but what is forming before it becomes consensus.
The companies that move on a signal before it becomes a story are the ones that win the quarter. We find those signals.
The companies
We're built for.
Healthcare · Payers · Health Systems
AI Healthcare
The companies rebuilding how health systems, payers, and employers buy, deliver, and pay for care. Revenue cycle, risk adjustment, prior authorization, clinical intelligence, medical coding. If your buyer is a CFO, CMO, or VP of Revenue Cycle — and your sales cycle is measured in quarters, not weeks — this is where I work.
Defense · Federal · Deep Tech
Resilient Infrastructure
The companies building systems that survive pressure and regenerate what's been broken. Defense-grade materials, critical mineral extraction, biotech for industrial applications, container security, federal AI. If your product is technically extraordinary but commercially early — this is the other place I work.
Compute · Neoclouds · Ecosystem
AI Infrastructure
The companies providing the compute backbone for the AI economy. If you're building or scaling a neocloud or AI infrastructure platform and need an ecosystem and partnerships function — someone who can source AI-native companies before their infrastructure decisions are locked in and activate distribution across healthcare, defense, and deep tech — this is the third place I work.
Early & growth-stage
Startups
Early and growth-stage companies building in AI healthcare, resilient infrastructure, and AI infrastructure that need commercial clarity, ecosystem access, or support preparing for a lead-backed financing.
Funds, syndicates & allocators
Investors
Funds, syndicates, and allocators looking for differentiated deal flow, market-formation intelligence, co-investment opportunities, and hands-on portfolio GTM support.
Tech, healthcare, life-sciences & industrial
Enterprises & Platforms
Technology, healthcare, life-sciences, industrial, and infrastructure organizations looking to commercialize innovation, enter new verticals, or build partnerships across the emerging AI ecosystem.
Deep
domain fluency.
- ✦AI-enabled revenue cycle and claims automation
- ✦Risk adjustment and medical coding intelligence
- ✦Prior authorization and medical necessity workflows
- ✦Clinical decision support and care delivery
- ✦Defense-grade materials and advanced manufacturing
- ✦Critical mineral extraction and environmental remediation
- ✦Container security and resilient infrastructure
- ✦AI compute, neocloud economics, and ecosystem development
- ✦GTM strategy and commercial architecture for deep tech
Engagement
models.
8–12 weeks · Fixed scope
Commercialization Strategy Sprint
One wedge, one market, one repeatable motion. You finish with a clear answer to who buys first, what proof they need, and what your next hire should be.
Ongoing retainer
Fractional GTM Advisory
We embed alongside the founding team as the commercial thinking partner — shaping narrative, opening doors, and building the motion as the company scales.
Funds & neoclouds · Startups
Ecosystem Partnership
For funds and neoclouds looking to identify and route high-potential companies before infrastructure and capital decisions are locked in. We source from the right cohorts, accelerators, and portfolios — connecting emerging companies to the right compute partners and helping funds build conviction in new verticals before the crowd gets there.
For startups, we build the ecosystem around you — identifying the right partners, opening the right doors, and creating the network infrastructure that accelerates distribution before you have the team to do it alone.
Embedded · Platform or Fund
Vertical Lead
We embed inside a platform, fund, infrastructure company, or startup to build and activate an ecosystem within a specific market segment from the ground up. That means identifying the right companies, mapping the partner landscape, designing the community architecture, and owning the relationships that turn a vertical from a thesis into a revenue-generating motion.
Ongoing · Intelligence-Led
Intelligence Retainer
For founders and funds who need to see the market forming before their competitors do. Sardis monitors your sector, your competitive landscape, and the regulatory and capital signals that change your commercial window — and delivers weekly intelligence specific to your buyer motion. You get the signal. You get the move. You get there first.
From qualified opportunity
to aligned capital.
Sardis works with a select number of companies where the market thesis, founder advantage, commercial timing, and financing structure are compelling. Where appropriate, we may help qualify the opportunity, develop investor conviction, organize interest through Sardis Circle, or introduce the company into an aligned co-syndication pathway.
Capital participation is considered independently from any Sardis advisory engagement. Every company and financing is evaluated individually, and no investment or syndication outcome is guaranteed.
Qualify
We assess the company, market, founder advantage, commercial traction, existing investors, terms, and strategic fit.
Structure
Where there is alignment, Sardis determines whether the appropriate path is a direct referral, a Sardis investor allocation, or a jointly syndicated vehicle.
Support
Sardis can remain useful after financing through GTM strategy, partnerships, buyer development, and ongoing market intelligence.
Matty Brownell
Chief Product Officer
Haven Health
Kirk brought a level of strategic clarity to Haven Health that we genuinely needed in our early stages. He pushed us to move away from stats-first messaging and think more about the emotional 'why' behind what we were building for the LGBTQ+ community. That reframe shaped how we talk about Haven externally. He had a sharp eye for simplicity, always pushing us toward the clearest, most direct path. His instinct to prove one channel before spreading thin kept our launch strategy sharper than it would have been otherwise. For any brand trying to build something meaningful at the intersection of mission and market, Kirk is the kind of strategic partner you want in your corner early.
Kirk
Brown.
Wharton GrAD
2x Founder
Venture Partner
Investor
"He works with founders who are building something genuinely hard — and need a commercial partner who can hold the complexity without flattening it."
Kirk Brown is a Wharton-trained operator, investor, and advisor and the founder of Sardis Capital Group. He works with companies building in AI healthcare, resilient infrastructure, and AI infrastructure, connecting market intelligence, commercial execution, ecosystem development, and selective co-investment.
He has built commercial engines across media, entertainment, and technology — with experience at Viacom and WME and growth work with brands including Hasbro, Logitech, PBS, Meta, and IBD where he led his department through acquisition.
He has advised early-stage companies across healthcare and infrastructure, and developed deep fluency in AI infrastructure, compute economics, and the neocloud ecosystem through direct engagement with frontier AI platforms.
His philanthropic work includes founding Melanin MeetUps, a global wellness and community platform with over 10,000 members across 15 cities, serving on the Board of The Whitney Plantation, and spearheading the Better Together Project — a 501(c)(3) aimed at memorializing plantations across the country.